ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:25 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 2,581,250 4.730% |
-175,000 (-6.35%) |
Filing |
| 2023-07-06 4:20 pm Purchase |
2023-06-26 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 2,756,250 5.450% |
1,293,750 (+88.46%) |
Filing |
| 2021-02-11 08:16 am Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 1,462,500 4.110% |
1,462,500 (New Position) |
Filing |